- Home
- COTY vs ROIV Comparison
COTY vs ROIV Comparison
Compare COTY & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COTY
- ROIV
- Stock Information
- Founded
- COTY 1904
- ROIV 2014
- Country
- COTY United States
- ROIV United Kingdom
- Employees
- COTY N/A
- ROIV N/A
- Industry
- COTY Package Goods/Cosmetics
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- COTY Consumer Discretionary
- ROIV Health Care
- Exchange
- COTY Nasdaq
- ROIV Nasdaq
- Market Cap
- COTY N/A
- ROIV 8.4B
- IPO Year
- COTY 2013
- ROIV N/A
- Fundamental
- Price
- COTY $7.78
- ROIV $11.82
- Analyst Decision
- COTY Buy
- ROIV Strong Buy
- Analyst Count
- COTY 14
- ROIV 10
- Target Price
- COTY $11.82
- ROIV $17.39
- AVG Volume (30 Days)
- COTY 5.3M
- ROIV 4.0M
- Earning Date
- COTY 11-06-2024
- ROIV 11-11-2024
- Dividend Yield
- COTY N/A
- ROIV N/A
- EPS Growth
- COTY N/A
- ROIV N/A
- EPS
- COTY 0.09
- ROIV 5.65
- Revenue
- COTY $6,118,000,000.00
- ROIV $158,303,000.00
- Revenue This Year
- COTY $7.62
- ROIV $53.59
- Revenue Next Year
- COTY $6.21
- ROIV $26.91
- P/E Ratio
- COTY $88.93
- ROIV $2.05
- Revenue Growth
- COTY 10.15
- ROIV 101.44
- 52 Week Low
- COTY $7.35
- ROIV $8.29
- 52 Week High
- COTY $13.30
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- COTY 35.92
- ROIV 47.60
- Support Level
- COTY $7.52
- ROIV $11.52
- Resistance Level
- COTY $7.71
- ROIV $12.08
- Average True Range (ATR)
- COTY 0.25
- ROIV 0.22
- MACD
- COTY -0.02
- ROIV -0.01
- Stochastic Oscillator
- COTY 23.04
- ROIV 29.40
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.